Guaifenesin And Pseudoephedrine Hydrochloride Tablet, Extended Release
Product Images NDC 62011-0475

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hydrochloride (NDC 62011-0475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strategic Sourcing Services Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (600 mg/60 mg Tablet Blister Pack Carton)

Principal Display Panel (600 mg/60 mg Tablet Blister Pack Carton)
Packaging label for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets, containing 600 mg Guaifenesin and 60 mg Pseudoephedrine HCl per tablet. The label shows the product name 'Mucus Relief D,' indicates 18 extended-release tablets per package, and lists the product as an expectorant and nasal decongestant. The labeler is Strategic Sourcing Services LLC, and it also includes usage, warnings, ingredients, and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.